Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,265 across all filing types
Latest filing 2020-10-15 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the launch of a pharmaceutical product, Acalabrutinib 100mg capsules (Calquence). It references a prior communication about regulatory approval (Form CT-20) and provides an update on the product launch date. The content is an announcement related to a product launch and does not contain financial data, management discussion, voting results, or regulatory filings related to financial performance or corporate governance. It is not a report, certification, or detailed financial disclosure. Given the nature of the document as a regulatory announcement to stock exchanges about a business update, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-10-15 English
This is to certify that, Integrated Registry Management Services Private Limited are the Company's Registrar and Transfer Agents and that all activities in relation to the share transfer ....
Regulatory Filings
2020-10-13 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates and the request for issuance of duplicate certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain financial data, management discussion, or report content. The document is short (1654 characters) and serves as an official notification to the exchanges about a specific shareholder matter. This fits the category of a Regulatory Filing (RNS) as it is a compliance-related announcement that does not fall under other specific categories like share issue, director dealings, or capital updates.
2020-09-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of share certificates and the request for issuance of duplicate certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain financial data, report content, or meeting materials. It is an official regulatory announcement related to share certificate status, not a financial report, meeting material, or voting result. The document length is short (1654 characters) and is a notification to the exchange, fitting the category of a general regulatory announcement. Therefore, it best fits the Regulatory Filings (RNS) category.
2020-09-29 English
Pursuant to the Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform you that a one-on-one meeting is scheduled to be held with analysts/investm
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled one-on-one meeting with analysts. It references Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document does not contain any financial data, detailed report, or results. It is an announcement of an upcoming interaction with analysts, not a report or transcript itself. Given the nature and length of the document, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of an interaction (one-on-one meeting) with analysts/investment managers. It references Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The document does not contain any financial data, results, or detailed reports. It is an announcement of an event related to investor relations rather than a financial report or detailed presentation. Given its nature and length (1386 characters), it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.